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ABSTRACT
Assembly of messenger ribonucleoparticles
(mRNPs) is a pivotal step in gene expression, but
only a few molecular mechanisms contributing to
its regulation have been described. Here, through
a comprehensive proteomic survey of mRNP
assembly, we demonstrate that the SUMO pathway
specifically controls the association of the THO
complex with mRNPs. We further show that the
THO complex, a key player in the interplay
between gene expression, mRNA export and
genetic stability, is sumoylated on its Hpr1 subunit
and that this modification regulates its association
with mRNPs. Altered recruitment of the THO
complex onto mRNPs in sumoylation-defective
mutants does not affect bulk mRNA export or
genetic stability, but impairs the expression of
acidic stress-induced genes and, consistently, com-
promises viability in acidic stress conditions.
Importantly, inactivation of the nuclear exosome
suppresses the phenotypes of the hpr1
non-sumoylatable mutant, showing that SUMO-de-
pendent mRNP assembly is critical to allow a
specific subset of mRNPs to escape degradation.
This article thus provides the first example of a
SUMO-dependent mRNP-assembly event allowing
a refined tuning of gene expression, in particular
under specific stress conditions.
INTRODUCTION
mRNA packaging into messenger ribonucleoparticles
(mRNPs) has emerged as a complex and highly regulated
process which differentially marks processed molecules,
directs them towards export, and dictates their stability,
subcellular localization and translation (1). Nuclear
mRNP assembly initiates with the cotranscriptional
recruitment of mRNA processing factors and several
other mRNA-associated proteins, some of which are
acting as adaptors for the mRNA-export machinery (2).
In budding yeast, Yra1, Nab2 and Npl3 serve as adaptors
for the Mex67-Mtr2 export receptor, which ultimately
brings mRNPs to the nuclear pore complex (NPC)
through interaction with nucleoporins (3). In addition,
cotranscriptional mRNP assembly has been shown to
involve THO, which is a conserved tetrameric complex
comprised of four subunits in yeast—Tho2, Hpr1, Mft1
and Thp2 (4). A pentameric version of THO, including the
conserved Tex1 protein, was also recently described (5).
The THO complex is associated with active genes and
contributes to the recruitment of several mRNA-
associated factors, including Sub2, Yra1 (6,7) and
SR-like proteins (Gbp2 and Hrb1) (8,9) which together
with THO form the so-called TREX (TRanscription and
EXport) complex, and Mex67 (10). Most likely as a con-
sequence of improper assembly, mRNPs formed in the
absence of the THO complex are retained in the nucleus
(7,11,12), and in some cases, degraded by the
exosome-associated 30–50 exonuclease Rrp6 (13,14).
THO complex inactivation also alters transcriptional
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elongation, in particular through G/C-rich, long and/or
repeat-containing genes (15–17) and provokes genetic
instability, as revealed by hyper-recombination pheno-
types (12,18). These phenotypes have been proposed to
involve R-loops, which are RNA::DNA hybrids that
accumulate in THO mutants (19,20).
As highlighted by several reports, changes in mRNP
composition occur precisely at distinct steps of mRNA
metabolism (1) whereas improperly assembled mRNPs
are carefully evicted in the cells (21,22). However, only a
limited number of spatio-temporal regulations targeting
mRNP composition have been described. RNA helicase-
dependent remodeling is best exempliﬁed by the action of
the DEAD-box ATPase Dbp5, which terminates the
mRNA export process at the cytoplasmic face of NPCs
through displacement of mRNA-associated export factors
such as Mex67 and Nab2 (23). In addition, changes in
mRNP composition can be driven by mutually exclusive
interactions involving mRNA-associated proteins and/or
the mRNA itself: Mex67 recruitment by Yra1 disrupts the
Yra1-Sub2 interaction in vitro (24), while in mammalian
cells, mRNA is handed over from adaptors to the export
receptor upon formation of a ternary complex (25).
Finally, a number of post-translational modiﬁcations tar-
geting mRNA-associated proteins were also demonstrated
to modulate mRNP content, impacting on mRNP stabil-
ity and/or nuclear export (26). Among known examples,
ubiquitination of Yra1 disrupts its interaction with
mRNPs prior to export (27) while Mex67 recruitment
onto transcribed genes is facilitated by ubiquitination of
the Hpr1 subunit of the THO complex (10).
Protein modiﬁcation by the small ubiquitin-like
modiﬁer SUMO, which has emerged as a key regulator
of multiple cellular processes (28), is also susceptible to
regulate mRNP assembly. This covalent, reversible modi-
ﬁcation has already been shown to ﬁnely tune several
aspects of mRNA metabolism, including transcription
and pre-mRNA processing (29,30). In addition, SUMO
conjugation often leads to conformational changes or
macromolecular complexes rearrangements (31), and
could therefore contribute to mRNP remodeling.
Finally, a number of enzymes of the SUMO pathway
are associated with nuclear pores, which represent the
ultimate route for exported mRNPs (30). In particular,
mRNPs committed for export are docked at the nuclear
basket of NPCs by virtue of their interaction with myosin-
like proteins (Mlp) 1 and 2 (32,33), which form a protein
platform also contributing to the anchoring of the
conserved SUMO-protease Ulp1 (34). Ulp1 (SENP2 in
mammals) is an essential SUMO-isopeptidase, which cata-
lyzes both the processing of neosynthesized SUMO prior
to conjugation, and the deconjugation of SUMO from its
targets (35). A few Ulp1 targets have been identiﬁed, but
to date, none of them has been associated with mRNA
metabolism (35).
Here, we have investigated the involvement of the
SUMO pathway, and in particular of the
SUMO-protease Ulp1, in mRNP assembly. Through a
comprehensive proteomic analysis of mRNP composition,
we demonstrate that Ulp1 speciﬁcally controls the associ-
ation of the THO complex with mRNPs. We further show
that the THO complex is sumoylated on its Hpr1 subunit
in a Ulp1-dependent manner, and that this modiﬁcation
regulates its association with mRNPs. Cells impaired in
SUMO-dependent THO complex recruitment exhibit
defective expression of acidic stress-inducible genes and,
consequently, fail to grow in acidic stress conditions.
Importantly, exosome inactivation restores both stress-
induced mRNA levels and viability on stress conditions,
indicating that defective expression of these mRNAs is
caused by mRNA degradation triggered by improper
mRNP assembly. This article thus shows that sumoylation
of the THO complex regulates mRNP biogenesis, thereby
contributing to optimal mRNA expression, as revealed
upon speciﬁc stress conditions.
MATERIALS AND METHODS
Yeast strains and plasmids
Unless otherwise indicated, all the strains used in this
study (listed in Supplementary Table S3) are isogenic to
S288C and were grown in liquid culture at 25C and
shifted for 2 h at 30C. For GAL gene induction, 2% gal-
actose was added for 2 h to cells grown in glycerol–lactate
(0.17% YNB, 0.5% ammonium sulfate, 0.05% glucose,
2% lactate and 2% glycerol) supplemented with the
required nutrients. For weak acid induction, cells were
grown on MM4 (minimal medium, pH4) supplemented
with 60mM acetic acid as described (36). When indicated,
cycloheximide (100 mg/ml, Sigma) or methylmethane sul-
fonate (MMS, 0.02%, Sigma) was added to the medium.
Construction of plasmids (listed in Supplementary
Table S4) was performed using standard molecular
cloning techniques. Sequences of oligonucleotides used
in this study are available upon request.
mRNP complexes puriﬁcation
mRNP puriﬁcation from cells expressing proteinA-tagged
baits was performed essentially as described (37). Brieﬂy,
frozen grindates were homogenized in nine volumes of
extraction buffer (20mM Hepes pH 7.5, 110mM KOAc,
2mM MgCl2, 0.1% Tween-20, 0,5% Triton X-100, 1mM
DTT, 1X protease inhibitors cocktail, complete
EDTA-free, Roche and antifoam B, Sigma, 1:5000).
When indicated, a 10-min treatment with RNAse
A (Sigma, 150 mg/ml) was included. The resulting extract
was clariﬁed by ﬁltration through 1.6mm GD/X Glass
Microﬁber syringe ﬁlters (25mm, Whatman) and further
incubated for 30min at 4C with IgG-conjugated
magnetic beads. Beads were then washed three times
with extraction buffer and once with 0.1M NH4OAc,
0.1mM MgCl2, 0.02% Tween-20. Bound-complexes
were eluted with 0.5M NH4OH, 0.5mM EDTA,
lyophilized and resuspended either in SDS-sample buffer
for SDS-PAGE or in 25mM ammonium carbonate for
mass spectrometry analysis.
Small-scale immunoprecipitations were performed
using IgG-conjugated magnetic beads or anti-HA
agarose beads (Pierce). Cells were lysed in the same
buffer as above by bead beating using a Fastprep
(Qbiogene). After a 10 000-g centrifugation at 4C for
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5min, the soluble extract was incubated with the beads for
30min (IgG immunoprecipitation) or 90min (anti-HA
immunoprecipitation) at 4C. Beads were washed three
times with extraction buffer and eluted with SDS sample
buffer.
Mass spectrometry analysis
Digestion was performed overnight at 37C in the
presence of 12.5mg/ml of sequencing grade trypsin
(Promega, Madison, Wi, USA). Digests were analyzed
by a LTQ Velos Orbitrap (Thermo Fisher Scientiﬁc, San
Jose, CA) coupled to an Easy nano-LC Proxeon system
(Thermo Fisher Scientiﬁc, San Jose, CA).
Chromatographic separation of peptides was performed
with the following parameters: column Easy Column
Proxeon C18 (10 cm, 75 mm i.d., 120A˚), 300 nl/min ﬂow,
gradient rising from 95% solvent A (water—0.1% formic
acid) to 25% B (100% acetonitrile, 0.1% formic acid) in
20min, then to 45% B in 40min and ﬁnally to 80% B in
10min. Peptides were analyzed in the Orbitrap in full ion
scan mode at a resolution of 30 000 and a mass range of
400–1800m/z. Fragments were obtained with a collision-
induced dissociation (CID) activation with a collisional
energy of 40%, an activation Q of 0.25 for 10ms and
analyzed in the LTQ. MS/MS data were acquired in a
data-dependent mode in which 20 most intense precursor
ions were isolated, with a dynamic exclusion of 20 s and an
exclusion mass width of 10 ppm. Data were processed with
Proteome Discoverer 1.4 software (Thermo Fisher scien-
tiﬁc, San Jose, CA) coupled to an in-house Mascot search
server (Matrix Science, Boston, MA; version 2.4.1). The
mass tolerance of fragment ions was set to 7 ppm for pre-
cursor ions and 0.5Da for fragments. The following modi-
ﬁcations were considered in mass calculation: oxidation
(M), phosphorylations (STY). The maximum number of
missed cleavages was limited to two for trypsin digestion.
MS/MS data were searched against the SwissProt
database (11/12/13 release) with the Saccharomyces
cerevisiae taxonomy. Percolator node was used for
peptide false discovery rate determination. Peptides were
validated when their q-value, which represents the
minimal false discovery rate at which the identiﬁcation is
considered correct, was below 1%.
Chromatin and RNA immunoprecipitation
Chromatin and RNA immunoprecipitations (ChIP and
RIP) were performed using a modiﬁed procedure (38).
Brieﬂy, cells were cross-linked in the presence of 1% for-
maldehyde for 10min at 25C. After quenching with
100mM glycine and washing with Tris-buffered saline,
the cell pellets were resuspended in 1ml lysis buffer
(50mM Hepes pH 7.5, 140mM NaCl, 1mM EDTA, 1%
triton X-100, 0.1% deoxycholate, 1X protease inhibitors
cocktail, complete EDTA-free, Roche) and lysis was
achieved by bead beating. Cell lysates were collected and
split in two parts, respectively, used for ChIP or RIP.
When used for ChIP, the cell lysate was further sonicated
to shear DNA using a Bioruptor (Diagenode) for two runs
of 10min each and solubilized chromatin was retrieved
through a 10min-centrifugation at 2500 g to prevent
differential chromatin fractionation (DCF) (38). When
used for RIP, the cell lysate was directly spun at 10 000 g
for 5min at 4C. Speciﬁc antibodies – anti-Hpr1 (39);
anti-RNAP II largest subunit (8WG16, Covance)—were
added to the relevant soluble extracts and immunopre-
cipitation was performed by overnight rotation at 4C.
Protein-G sepharose beads (GE Healthcare) were added
to the samples for two additional hours. Washes were as
follow: twice with lysis buffer, twice with lysis buffer con-
taining 360mM NaCl; twice with 10mM Tris pH 8,
250mM LiCl, 0.5% Nonidet-P40, 0.5% deoxycholate,
1mM EDTA and once with 10mM Tris–HCl pH 8,
1mM EDTA.
Elution was achieved through a 20-min incubation at
65C in the presence of 50mM Tris pH 8, 10mM EDTA,
1% SDS. The eluate was deproteinized with proteinase K
(Sigma, 0.2mg/mL) and uncrosslinked for 30min at 65C.
Immunoprecipitated nucleic acids (DNA or RNA) were
puriﬁed with the Qiaquick PCR puriﬁcation kit (Qiagen)
and the Nucleospin RNAII kit (Macherey Nagel), respect-
ively. RNAs were reverse-transcribed with AMV reverse
transcriptase (Finnzymes). DNA and cDNA were further
quantiﬁed by real-time PCR with a LightCycler 480
system (Roche) according to the manufacturer’s instruc-
tions. Controls without reverse transcriptase allowed
estimating the lack of contaminating DNA. RIP (or
ChIP) values are the ratios between immunoprecipitated
RNA (or DNA) and input RNA (or DNA) amounts. For
Hpr1 ChIP, values were further normalized to the ChIP
value of RNAP II as described (40). For Hpr1 RIP and
ChIP, values were set to 1 for hpr1D cells (negative control
for anti-Hpr1 immunoprecipitation).
DCF analyses were performed as described (41).
SUMO-conjugates isolation
SUMO-conjugates were isolated from yeast cells express-
ing a His-tagged version of SUMO under the control of
the copper-inducible CUP1 promoter. Brieﬂy, 100 OD600
of cells induced during 4 h in the presence of 0.1mM
CuSO4 were harvested and further processed for nickel
agarose denaturing chromatography using reported
methods (42) with the following changes. Cells were
directly lysed by bead beating in 6M guanidine HCl,
100mM sodium phosphate pH8, 10mM Tris HCl, 0.1%
TritonX-100, 10mM beta-mercaptoethanol, 50mM N-
ethylmaleimide (Sigma). Clariﬁed lysates were incubated
with Ni-NTA agarose beads (Qiagen) for 2 h at room tem-
perature. Beads were washed twice with lysis buffer and
three times with 8M urea, 100mM sodium phosphate,
10mM Tris HCl pH 6.3 before proceeding to elution.
Western-blot analysis
Total protein extraction from yeast cells was performed by
the NaOH–TCA lysis method (42). Samples were
separated on 4–12% SDS-PAGE gel and transferred to
PVDF membranes. Western-blot analysis was performed
using the following antibodies: rabbit IgG-HRP poly-
clonal antibody (Dakocytomation), 1:5000; monoclonal
anti-GFP (Roche Diagnostics), 1:500; monoclonal
anti-HA (Covance), 1:1000; monoclonal anti-Pab1
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(Santa-Cruz), 1:1000; polyclonal anti-Yra1 (6), 1:1000;
polyclonal anti-Nab2 (32), 1:100 000; polyclonal anti-
Hpr1 (39), 1:1000; and polyclonal anti-Mex67 (39),
1:50 000. Quantiﬁcation of signals was performed based
on serial dilutions of reference samples using the ImageJ
software.
Gene expression analysis
Total RNAs were extracted from yeast cultures using
Nucleospin RNA II (Macherey Nagel). For RT-qPCR,
RNAs were reverse-transcribed with AMV reverse tran-
scriptase (Finnzymes) and cDNA quantiﬁcation was
achieved through quantitative real-time PCR as above.
For microarray analysis, 1 mg of total RNA was reverse
transcribed and labeled with Cy5 or Cy3 using the
amino-allyl protocol described at transcriptome.ens.fr/
sgdb/protocols/. A set of 52 519 probes matching the
ORFs of S. cerevisiae, with 1–15 speciﬁc probes per
gene, was designed using the Teolen software, with
default parameters (43). This probe design was deposited
on the earray database (AMADID: 027945) and was used
to produce Agilent arrays in a 8 60 k format. These
Agilent arrays were hybridized with the labeled cDNA
using the Agilent hybridization protocol. After washing
following the supplier’s recommendations, the slides
were scanned using a 2-micron Agilent microarray
scanner. The images were analyzed using the feature ex-
traction software and normalized by global lowess using
Goulphar (44). For each gene, the Cy5/Cy3 ratios corres-
ponding to the different probes were averaged. The hpr1-
KR versus wt comparison was performed twice using in-
dependent samples and dye swap. The averaged log2 of the
mutant/wild-type ratios and the standard deviation
between the two replicates were calculated for each gene.
The genes showing a standard deviation >0.5 were
removed from the data. This ﬁlter eliminated 150
genes which were highly variable between replicates. The
complete microarray data are available in Supplementary
Table S2 and in the ArrayExpress database (www.ebi.ac.
uk/arrayexpress) under accession number E-MTAB-2138.
Cells carrying LacZ reporters were lysed and assayed
for b-galactosidase activity using the NovaBrightTM
b-galactosidase Chemiluminescent Detection System
(Invitrogen) following the manufacturer’s instructions.
Relative light units were normalized to the amount of
cells as estimated by measurement of the OD at 600 nm.
Miscellaneous
Fluorescence in situ hybridization (FISH) was carried out
on ﬁxed cells using a Cy3-(dT)50 probe (45). Wide-ﬁeld
ﬂuorescence images were acquired using a DM6000B
Leica microscope with a 100, NA 1.4 (HCX Plan-Apo)
oil immersion objective and a CCD camera (CoolSNAP
HQ; Photometrics). For Rad52 foci analysis, z-stacks
sections of 0.2mm were acquired using a piezo-electric
motor (LVDT; Physik Instrument) mounted underneath
the objective lens. Images were scaled equivalently and
3D-projected using MetaMorph 5 (Universal Imaging),
and further processed with Photoshop CS2 9.0 software
(Adobe).
Hyper-recombination rates were determined as the
frequency of deletions of the chromosomal leu2-k::
ADE2-URA3::leu2-k system based on two 2.16-kb leu2
repeats as previously described (46).
RESULTS
A proteomic survey of SUMO function in mRNP
assembly
To understand the contribution of sumoylation to mRNP
assembly and export, we undertook a proteomic analysis
of mRNPs isolated from cells carrying a thermosensitive
allele of ULP1 disturbing SUMO-conjugates metabolism
(ulp1-333, thereafter referred as ulp1) (47). The ulp1 cells
exhibit both impaired deconjugation and reduced SUMO
processing at semi-restrictive temperature, thereby
allowing to assess the global impact of the SUMO
pathway on mRNP assembly. Using a reported procedure
maintaining mRNP integrity (37), mRNPs were puriﬁed
from wt or ulp1 cells expressing a tagged version of
the small subunit of the nuclear cap-binding complex
(Cbp20/Cbc2-protA) and analyzed by SDS-PAGE and
silver staining (Figure 1A), or by mass spectrometry
(Supplementary Table S1A). Consistent with previous
proteomic analysis of Cbp80-associated mRNPs (37),
Cbc2-associated proteins puriﬁed from wt cells included
a wide range of mRNAs-associated proteins such as
splicing, 30-end processing and mRNA export factors
(n=85, Supplementary Figure S1A and Table S1A).
The sensitivity of this proteomic analysis and its selectivity
for mRNP components were highlighted by the large
number of recovered interactants (Supplementary
Table S1A) and the RNAse-sensitive association of most
identiﬁed proteins (Supplementary Table S1B and
Figure S1B), respectively. These analyses revealed that
the overall composition of Cbc2-associated mRNPs was
not drastically altered upon ULP1 loss-of-function,
indicating that bulk mRNP assembly does not require
the SUMO pathway (Figure 1A and B and
Supplementary Table S1B). Remarkably however, out of
the Cbc2-associated mRNP components whose mass spec-
trometry scores were strongly altered in the ulp1 mutant,
four corresponded to subunits of the tetrameric THO
complex (Tho2, Hpr1, Mft1, Thp2; Supplementary
Figure S1A and Table S1B).
To extend our proteomic survey of mRNP composition,
we also examined the protein content of nuclear pore-
associated mRNPs. Proteomic analysis of Mlp2 interact-
ants unraveled a comprehensive network of proteins
including all known nucleoporins, spindle pole body com-
ponents (48), the 26S proteasome (49) and novel partners
(Figure 1D and Supplementary Table S1A). Among them,
expanding previous ﬁndings (32,33), we identiﬁed several
mRNP components (n=34), whose RNA-dependent
association with nuclear pores was conﬁrmed by RNAse
treatment (Supplementary Table S1B and Figure S1C).
Importantly, the protein contents of Cbc2- and
Mlp2-associated mRNPs were overlapping but clearly
distinct (Supplementary Figure S1A and Table S1A),
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thus validating our approach as appropriate to detect
changes in mRNP composition. In particular, Cbc2-
associated mRNPs contained multiple splicing factors,
whereas, consistent with reported nuclear mRNP remodel-
ing (37), Mlp2-associated mRNPs speciﬁcally encom-
passed late export factors such as Dbp5 or TREX-2
(transcription and export 2, also referred to as THSC), a
conserved multi-protein mRNA export factor located to
the inner face of NPCs (50). The overall composition of
Mlp2-associated mRNPs did not exhibit strong variations
upon ULP1 loss-of-function (Figure 1D and
Supplementary Table S1B), indicating that the SUMO
pathway is not required for mRNP docking at nuclear
pores. However, mass spectrometry scores of the
THO complex subunits recovered in the Mlp2-associated
mRNPs were also decreased upon ULP1 loss-of-function
(Supplementary Table S1B). This proteomic survey
thus identiﬁed THO complex subunits as a set of
mRNP-associated proteins whose recruitment to both
Cbc2- and Mlp2-associated mRNPs could depend on
Ulp1 activity, and therefore, on SUMO metabolism.
Although Ulp1 may also affect the recruitment of other
mRNA-associated factors (Supplementary Table S1B), we
focused our subsequent study on the THO complex.
Figure 1. A proteomic survey of SUMO function in mRNP assembly. (A) Cbc2-protA associated mRNPs (‘IP’) isolated from wt and ulp1 cells were
analyzed by SDS-PAGE followed by silver staining. Position of the Cbc2-protA-tagged protein is indicated. (B) Soluble extracts (left panel, ‘inputs’)
and Cbc2-protA-associated mRNPs (mid panel, ‘IP’) isolated from wt and ulp1 cells were analyzed by immunoblotting using the indicated antibodies.
Decreasing amounts (ml) of a wt reference sample (right panel) were loaded to allow quantiﬁcation. (C) The relative amounts of Hpr1 and Mex67
associated to Cbc2-bound mRNPs (mean±SD; n=2) were quantiﬁed from (B). Signals recorded in ‘no tag’ lanes were subtracted and values were
normalized to the amounts of immunoprecipitated Cbc2 and set to 1 for wt. (D, E and F) same as (A, B and C), for Mlp2-protA-associated proteins.
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SUMO regulates the association of the THO complex
with mRNPs
To validate the predictions from our qualitative proteomic
analysis, we used the same Cbc2- and Mlp2-tagged strains
for small-scale immunopuriﬁcations of mRNPs followed
by western-blot analysis with a panel of antibodies for
representative mRNP components. This approach con-
ﬁrmed that ULP1 inactivation decreases the association
of the Hpr1 subunit of the THO complex to Cbc2-
(Figure 1B and C) and Mlp2-associated mRNPs (Figure
1E and F) while other components (Mex67, Yra1, Nab2,
Pab1) remain unaffected. The SUMO pathway is, there-
fore, speciﬁcally required for proper association of the
THO complex with mRNPs at various stages of the
export process.
In parallel, we examined the recruitment of the THO
complex onto speciﬁc target mRNAs using RNA
immunoprecipitation (RIP) with a speciﬁc anti-Hpr1
antibody. Following immunoprecipitation, target mRNAs
(PMA1, ADH1, YEF3) selected according to previous
genome-wide analysis of THO complex recruitment (17)
were quantiﬁed by RT-qPCR (Figure 2A). This approach
detected a uniform association of the THO complex along
mRNAs that decreased upon inactivation of ULP1 (Figure
2B), further strengthening the outcome of our mRNPs
proteomic analysis.
We next used chromatin immunoprecipitation (ChIP)
to determine the consequences of ULP1 inactivation on
the recruitment of the THO complex onto RNAP II-
transcribed genes (6,7,17). This analysis revealed that the
association of the THO complex to its aforementioned
target genes (PMA1, ADH1, YEF3) was not altered by
ULP1 loss-of-function (Figure 2C). Our data thus indicate
that this SUMO-protease mainly regulates the association
of the THO complex with mRNPs.
Figure 2. SUMO regulates the recruitment of the whole THO complex within mRNPs. (A) RIP and and ChIP experimental design. See Materials
and methods section for details. (B and C) Hpr1 binding onto the indicated mRNAs (B) (RIP Hpr1) and genes (C) (ChIP Hpr1) was quantiﬁed by
qPCR using speciﬁc primer pairs. The positions of the primers along the PMA1 gene are indicated. RIP (or ChIP) values (mean±SD; n=3) are the
ratios between immunoprecipitated RNA (or DNA) and input RNA (or DNA) amounts. For ChIP, values were further normalized to the ChIP
value of RNAP II. In all cases, values were set to 1 for hpr1D cells (negative control for anti-Hpr1 immunoprecipitation). n.d., not detectable;
*P< 0.05 (Student’s t-test). (D) Soluble extracts from wt, THP2-HA, THP2-HA ulp1, MFT1-HA, MFT1-HA ulp1, THO2-HA or THO2-HA ulp1 cells
were used for anti-HA immunoprecipitation. Soluble extracts (left panels, ‘inputs’) and immunoprecipitated material (right panels, ‘a-HA IP’) were
analyzed by western blotting using anti-Hpr1 (top panels) and anti-HA (lower panels) antibodies. Note that Hpr1 levels are slightly decreased in the
presence of HA tags on Mft1 or Tho2; however, each of these HA-tagged subunits coimmunoprecipitate equivalent amounts of Hpr1 from wt and
ulp1 extracts.
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To determine whether these defects were due to
impaired THO complex assembly, immunoprecipitation
experiments were carried out in wt and ulp1 cells. This
analysis revealed equivalent coimmunoprecipitation of
Hpr1 with Thp2, Mft1 or Tho2 subunits, respectively,
from wt and ulp1 cell extracts (Figure 2D). These results
indicate that the ulp1 mutant is not affected for bulk THO
complex assembly. Taken together, our results therefore
establish that the SUMO-protease Ulp1, and consequently
the SUMO pathway, contributes to the recruitment of the
whole THO complex onto mRNPs.
The THO complex is sumoylated on the C-terminus of its
Hpr1 subunit
To determine if the THO complex could be a sumoylated
target of Ulp1, cellular SUMO-conjugates were puriﬁed by
denaturing Ni2+ chromatography from strains expressing a
poly-histidine-tagged version of SUMO and HA-tagged
versions of each of the THO complex subunits. This
assay did not detect any sumoylated versions of Tho2,
Mft1 and Thp2 subunits (Supplementary Figure S2A). In
contrary, small amounts of sumoylated Hpr1 were detect-
able in SUMO-conjugates fractions from cells coexpressing
Hpr1-HA and His-SUMO (Figure 3A, lane 4, compare
with lanes 1 and 3). Importantly, sumoylated Hpr1 was
also detectable in cells from an unrelated genetic back-
ground (W303; Supplementary Figure S2A). These
modiﬁed forms were unlikely to correspond to
ubiquitinated versions of Hpr1, which are solely detectable
in the context of proteasome inhibition (39). In addition,
these modiﬁed forms of Hpr1 were lost upon simultaneous
inactivation of the two major SUMO ligases Siz1 and Siz2
(Figure 3B), conﬁrming their sumoylated nature.
Importantly, the same approach uncovered an accumula-
tion of sumoylated Hpr1 in ulp1 mutant cells (Figure 3A,
compare lanes 6 and 4), demonstrating that the
SUMO-protease Ulp1 targets the THO complex for
desumoylation on its Hpr1 subunit.
To further characterize Hpr1 sumoylation, we went on
to determine the lysine residues within Hpr1 that are
modiﬁed by SUMO. For this purpose, we generated
several plasmid-based Hpr1 mutants where multiple
lysines were mutated to arginines to prevent SUMO con-
jugation without disturbing the charge of the protein
(Figure 3C) and expressed them in hpr1D cells.
Simultaneous mutation of the ﬁrst 31 (K1-31R) or the fol-
lowing 14 (K32-45R) lysine residues did not affect the
sumoylation level of Hpr1 (Figure 3D, compare lanes 4,
5 and 3). In contrast, mutation of the last 20 lysines within
Hpr1 C-terminus (K46-65R) completely abolished its
sumoylation (Figure 3D, compare lanes 6 and 3). Within
this C-terminal domain, mutation of lysine 46–59
(K46-50R or K51-59R) did not prevent Hpr1 sumoylation,
while simultaneous mutation of lysines 60–65 (K60-65R)
fully abrogated this modiﬁcation (Figure 3D, compare
lanes 10 and 7).
Similar results were obtained when the hpr1-K60-65R-
HA allele was integrated at the HPR1 locus (Figure 3E).
Within this domain, the SUMOplot software
(abgent.com/sumoplot) identiﬁed lysine 60 as the unique
site with a high probability of modiﬁcation. However, sub-
stitution of lysines 60 and 61 did not affect Hpr1
sumoylation in our in vivo assay (H. Bretes et al., unpub-
lished results). This is in agreement with numerous reports
where mutation of single lysines does not abrogate
monosumoylation and results in sumoylation at an
adjacent site (51–53). Taken together, our results thus
indicate that the THO complex is sumoylated on the
C-terminus of Hpr1.
THO complex sumoylation occurs independent of its
ubiquitination
Ubiquitination was previously demonstrated to target
Hpr1 for proteasomal degradation (39). In conditions
where sumoylated Hpr1 readily accumulates (e.g. in the
ulp1 mutant, Figure 3A), the degradation rates of Hpr1 or
other THO complex subunits were not altered (Figure 4A
and B). Similarly, in conditions where Hpr1 sumoylation
is prevented (e.g. in the siz1 siz2 SUMO ligase mutant, or
in the hpr1-K60-65R mutant, see Figure 3B and E), the
global turnover of Hpr1 remained unaffected (Figure 4C
and D). These results thus demonstrate that sumoylation
of Hpr1 neither prevents, nor stimulates its ubiquitin-de-
pendent degradation.
In contrast, simultaneous mutations of lysines 51–59 led
to a strong accumulation of the Hpr1 protein (Figure 4E
and F; see also Figure 3D, compare lane 9 and 7, or 19
and 17), indicating that these lysines likely contribute to
Hpr1 ubiquitin-dependent proteasomal degradation.
Importantly, the Hpr1-K51-59R mutant protein was still
sumoylated (Figure 3D), showing that Hpr1
ubiquitination does not modulate its sumoylation. Of
note, Hpr1 C-terminus (residues 548–752) was identiﬁed
as a partner of the ubiquitin-associated domain of Mex67
in the two-hybrid assay (10) and Hpr1 degradation was
shown to be slowed down upon deletion of its last 88
aminoacids (39). Together with our results, these data
strongly suggest that within lysine 51–59, lysines 58 and
59 are the major residues involved in ubiquitin-dependent
degradation of Hpr1 (Figure 4G).
Interestingly, secondary-structure-prediction programs
detect with a high probability the presence of an intrinsic-
ally disordered domain in this region of the Hpr1 protein
(residues 667–752; Supplementary Figure S2B). Such
domains have been demonstrated to be particularly
prone to modiﬁcation by ubiquitin (54) and ubiquitin-
like modiﬁers (55). Together, our data reveal that
ubiquitination and sumoylation occur independently on
distinct residues within a short and likely disordered
domain at the C-terminus of Hpr1.
THO complex sumoylation regulates its association with
mRNPs
Although HPR1 deletion differentially impacted viability
depending on the temperature and the genetic back-
ground, these growth defects were fully rescued by expres-
sion of the Hpr1-K60-65R protein (Figure 5A). Since this
allele does not impair Hpr1 ubiquitination and comple-
ments HPR1 deletion, it was further used as a speciﬁc
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Figure 3. The THO complex is sumoylated on the C-terminus of its Hpr1 subunit. (A) Denatured lysates from wt or ulp1 cells expressing a HA-
tagged version of Hpr1 and/or a His-tagged version of SUMO (+/) were used for nickel chromatography. Total lysates (‘inputs’, bottom panel) and
puriﬁed His-SUMO conjugates (top panel) were analyzed by western blotting using anti-HA antibodies. Closed circles show the position of
sumoylated Hpr1. Open circles show the position of an anti-HA non-speciﬁc reactive band. Note that the non-speciﬁc binding of a fraction of
non-sumoylated Hpr1-HA (also observed in the absence of His-SUMO, lanes 3 and 5) is a classical issue in SUMO-conjugates puriﬁcation (see
Supplementary Figure S2A). (B) The same analysis as in (A) was performed with lysates from wt and siz1D siz2D cells expressing His-SUMO (+). (C)
Design of the hpr1-KR mutant alleles. The positions of the lysine residues mutated in these mutants are indicated by dashes along the protein
sequence. (D) The same analysis as in (A) was performed with lysates from hpr1D cells expressing plasmid-borne lysine mutants of HA-tagged Hpr1
and/or His-SUMO (+/). Total lysates (‘inputs’, bottom panels) and puriﬁed His-SUMO conjugates (top panels) were analyzed by western blotting
using anti-HA antibodies. (E) The same analysis as in (D) was performed with lysates from cells expressing a genomically HA-tagged version of
Hpr1, either wt or K60-65R. Molecular weights are indicated (kDa).
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Figure 4. THO complex sumoylation occurs independent of its ubiquitin-dependent degradation. (A) Protein levels of Hpr1- and HA-tagged versions
of other THO complex subunits were analyzed in wt and ulp1 cells treated with cycloheximide (CX) for the indicated time (minutes). Whole cell
extracts were analyzed by western blotting using anti-Hpr1 or anti-HA antibodies. (B) The relative amounts of the indicated proteins (mean±SD;
n=3) were quantiﬁed over time in wt and ulp1 cells following CX treatment. The quantities of proteins were determined using ImageJ and are
expressed relative to t=0. Note that the different THO subunits exhibit distinct half-lives; however, their decay is overall similar in wt and ulp1 cells.
(C) Same as (A), in wt, siz1D siz2D and hpr1-K60-65R cells. (D) Same as (B), in wt, siz1D siz2D and hpr1-K60-65R cells. (E) Protein levels of Hpr1
were analyzed in hpr1D cells expressing HA-tagged versions of wt Hpr1 or Hpr1-K51-59R. Whole-cell extracts (decreasing amounts, in ml) were
analyzed by western blotting using anti-HA (top panel) and anti-Pab1 (lower panel) antibodies. (F) The amounts of Hpr1 (relative to the loading
control Pab1, mean±SD; n=2) were determined using ImageJ. (G) Map of Hpr1 lysine residues. The domains encompassing the lysine residues
targeted by sumoylation (‘SUMO, K60-65’) or required for ubiquitin-dependent turnover (‘ubi, K51-59’) are indicated. [1] Interaction domain
reported for Mex67 ubiquitin-associated domain (UBA) (10); [2] domain deleted in the reportedly stabilized hpr1D88 mutant (39). Numbers
refers to the amino acid positions.
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Figure 5. THO complex sumoylation regulates its association with mRNPs. (A) Serial dilutions of the indicated strains were grown on YPD plates at
the indicated temperature (hpr1KR=hpr1-K60-65R). The genetic background is indicated (S288C or W303). (B) Soluble extracts (left panel, ‘inputs’)
and Cbc2-protA associated mRNPs (right panel, ‘IP’) isolated from the indicated strains were analyzed by immunoblotting using the indicated
antibodies. (C) The relative amounts of Hpr1 and Mex67 associated to Cbc2-bound mRNPs were quantiﬁed from (B). Values (mean±SD; n=2)
were normalized to the amounts of immunoprecipitated Cbc2 and set to 1 for wt. (D) Hpr1 binding onto the indicated mRNAs was quantiﬁed in the
indicated strains by RIP using an anti-Hpr1 antibody followed by RT-qPCR using speciﬁc primer pairs. The positions of the primers along the
PMA1 gene are indicated. RIP values (mean±SD; n=3) are the ratios between immunoprecipitated and input RNA amounts. Values were set to 1










non-sumoylatable hpr1 mutant in our next studies (subse-
quently referred to as hpr1-KR).
To evaluate the impact of Hpr1 sumoylation on THO
complex association with mRNAs, we analyzed the
recruitment of the hpr1-KR mutant protein into
Cbc2-associated mRNPs. This revealed a reduced associ-
ation of the non-sumoylatable hpr1-KR protein with
mRNPs as compared to wt Hpr1 (Figure 5B, compare
lanes 5 and 6; Figure 5C). To better quantify this
decreased recruitment, we performed RIP in the same
mutants (Figure 5D). This approach conﬁrmed the
reduced association of the non-sumoylatable hpr1-KR
mutant with its target mRNAs (Figure 5D). Both
approaches further revealed that unlike in HPR1 wt
cells, the decreased recruitment observed in hpr1-KR
cells was not further enhanced by ULP1 inactivation
(Figure 5B, compare lanes 6 and 8; Figure 5C and D).
This strongly supports that a sumoylation/desumoylation
cycle occurring on the C-terminal domain of Hpr1
contributes to its recruitment onto mRNPs.
Importantly, sumoylation did not impair the bulk
association of Hpr1 with the THO complex, as revealed
by the similar coimmunoprecipitation of both Hpr1 and
hpr1-KR with HA-tagged Thp2, Mft1 or Tho2
(Figure 5E). Although we cannot formally exclude that
the assembly of the speciﬁc mRNP-associated fraction of
the THO complex could be altered in hpr1-KR and ulp1
mutants, our data indicate that Hpr1 sumoylation likely
regulates the recruitment of the entire THO complex onto
mRNPs.
THO complex sumoylation does not impact on genetic
stability and bulk mRNA export
In view of the described functions of the THO complex,
we next analyzed the consequences of impaired Hpr1
sumoylation on genetic stability, mRNA export and
mRNA expression. Unlike THO-inactivation mutants
(hpr1D) (18), mutants affecting THO complex
sumoylation (hpr1-KR, ulp1) do not display increased
recombination between direct chromosomal repeats
(Supplementary Figure S3A). In addition, impairing
sumoylation of Hpr1 does not lead to synthetic lethality
when combined with DNA damage checkpoint mutants
(Supplementary Figure S3B and H. Bretes et al., unpub-
lished results), a phenotype previously reported for THO
null mutants (56). Finally, unlike hpr1D cells (56),
hpr1-KR cells do not exhibit an increased occurrence of
DNA double-strand break-repair foci labeled by Rad52
(Supplementary Figure S3C). Taken together, these data
show that THO complex sumoylation does not impact on
genetic stability.
Recruitment of known THO complex-dependent
mRNP components such as Mex67 was not detectably
affected by changes in Hpr1 sumoylation in the ulp1 or
hpr1-KR mutants (see Figures 1B and E and 5B). In agree-
ment with these biochemical data, the ulp1 and hpr1-KR
mutants did not exhibit bulk mRNA export defects, as
probed by FISH analysis of poly-A+ RNAs
(Supplementary Figure S4A). These results indicate that
while THO complex sumoylation regulates its own asso-
ciation with mRNPs, it does not further affect mRNP
export.
THO complex sumoylation is required for the expression
of stress-inducible genes and for viability upon stress
conditions
To gain insight into the impact of THO complex
sumoylation on gene expression, we ﬁrst analyzed the
expression of the bacterial LacZ gene, a reporter typically
affected in THO mutants. Beta-galactosidase assays
revealed a mild yet signiﬁcant reduction of LacZ expres-
sion in hpr1-KR cells as compared to wt (Supplementary
Figure S4B).
This result prompted us to characterize the impact of
THO complex sumoylation on endogenous gene expres-
sion. Total RNAs were extracted from wt and hpr1-KR
cells and transcriptome proﬁles were analyzed by micro-
array. Preventing Hpr1 sumoylation (hpr1-KR) did not
cause extensive changes in gene expression at the
genomic level (Figure 6A). Indeed, only 41 genes exhibited
mRNA levels at least 1.5-fold above or below the wt
values in hpr1-KR cells (Supplementary Table S2), thus
differing from the reported genome-wide impact of THO
inactivation (811 genes affected in hpr1D cells) (17). In
addition, only a very limited number of genes exhibited
consistent changes between two replicate experiments.
Among them, the only clear functional enrichment was
observed for genes involved in the adaptive response to
chemical stresses caused by lowered pH (Haa1 regulon).
These genes (YRO2, TPO2, TDA6, HSP30, YLR297w,
YDR222w, TPO3, indicated on Figure 6A) were therefore
selected for further studies.
To conﬁrm that Hpr1 sumoylation is required for the
expression of this subset of genes, wt and hpr1-KR cells
were grown in conditions of induction of the Haa1
regulon, e.g. minimal media (MM4) supplemented with
acetic acid (36). In agreement with previous reports (57),
acid treatment lead to an increased expression of the
considered genes in wt cells, as revealed by RT-qPCR
(YRO2, TDA6, TPO2, TPO3 panels; Figure 6B).
Importantly, hpr1-KR cells speciﬁcally exhibited reduced
mRNA levels for these genes (Figure 6B, compare with the
ACT1 panel).
Expression of genes of the Haa1 regulon is essential for
cell survival upon acidic stress (36). Strikingly, impairing
Hpr1 sumoylation (hpr1-KR) similarly affected viability
Figure 5. Continued
for hpr1D cells (negative control for anti-Hpr1 immunoprecipitation). n.d., not detectable. *P< 0.05 (Student’s t-test, compared to wt). (E) Soluble
extracts from wt, THP2-HA, THP2-HA hpr1-KR, MFT1-HA, MFT1-HA hpr1-KR, THO2-HA or THO2-HA hpr1-KR cells were used for anti-HA
immunoprecipitation. Soluble extracts (left panels, ‘inputs’) and immunoprecipitated material (right panels, ‘a-HA IP’) were analyzed by western
blotting using anti-Hpr1 (top panels) and anti-HA (lower panels) antibodies. Note that Hpr1 levels are slightly decreased in the presence of HA tags
on Mft1 or Tho2; however, each of these HA-tagged subunits coimmunoprecipitate equivalent amounts of Hpr1 from wt and hpr1-KR extracts.
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Figure 6. THO complex sumoylation is required for the expression of stress-inducible genes and for viability upon stress conditions. (A) Transcriptome
analysis of the hpr1-KR mutant (MA plot). The Y-axis (M) is the averaged log2 of the hpr1-KR/wt ratios calculated from two independent microarray
hybridizations. The X-axis (A) is the log2 of the averaged ﬂuorescence intensities. The genes belonging to the Haa1 regulon, which have been further
investigated, are highlighted. The complete dataset used to draw this graph is available in Supplementary Table S2. (B) mRNA levels for the YRO2,
TDA6, TPO2, TPO3, ACT1 and HAA1 genes were measured by RT-qPCR (normalized to 25S rRNA values, mean±SD; n=3) in the indicated strains
grown in MM4 medium and treated or not for 30min with 60mM acetic acid. *P< 0.05 (Student’s t-test, compared to wt). (C) Serial dilutions of the
indicated strains were grown at 30C on MM4 solid medium supplemented or not with 60mM acetic acid. (D) Hpr1 binding onto the indicated mRNAs
was quantiﬁed by RIP using an anti-Hpr1 antibody followed by RT-qPCR using speciﬁc primer pairs. RIP values (mean±SD; n=3) are the ratios
between immunoprecipitated and input RNA amounts. Values were set to 1 (dotted line) for hpr1D cells (negative control for anti-Hpr1 immunopre-
cipitation). *P< 0.05 (Student’s t-test, compared to wt).
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on acetic acid-containing media (Figure 6C). Notably, the
growth defect of hpr1-KR cells recorded on acid-contain-
ing media was also observed in an unrelated genetic back-
ground, albeit to a lower extent (W303; Supplementary
Figure S5A). However, this phenotype did not reﬂect a
general sensitivity of the hpr1-KR mutant to stress condi-
tions (Supplementary Figure S5B). In particular, unlike
THO inactivation mutants (13), hpr1-KR cells did not
display heat sensitivity (Figure 5A) or 30-end degradation
of the heat-shock induced HSP104 transcript
(Supplementary Figure S5C). Taken together, our results
thus establish that Hpr1 sumoylation is critical for the
optimal expression of a subset of stress-inducible genes
(e.g. the Haa1 regulon) and subsequently, for viability in
the corresponding stress conditions.
Improperly assembled mRNPs are targeted for
degradation by the exosome in THO sumoylation mutants
We ﬁrst conﬁrmed that sumoylation of Hpr1 also
regulates THO complex association with acid-induced
mRNAs. RIP analyses indeed revealed that both
hpr1-KR and ulp1 cells exhibit decreased association of
the THO complex with TPO2 and YRO2 mRNAs
(Figure 6D).
The expression of this subset of genes is notably
regulated by the Haa1 transcriptional activator (58).
However, hpr1-KR cells were not affected for the expres-
sion of the HAA1 mRNA (Figure 6B). In addition, the
effect of the hpr1-KR mutant was observed both in
uninduced and acid-induced conditions (Figure 6B).
Furthermore, RNAP II recruitment along acid-induced
genes was not affected in hpr1-KR cells (Supplementary
Figure S5D). These results therefore suggest that the
observed effects on the Haa1 regulon in hpr1-KR cells
are post-transcriptional.
To assess whether improper mRNP assembly triggers
increased degradation of mRNAs of the Haa1 regulon,
the hpr1-KR allele was combined with the inactivation of
the Rrp6 subunit of the exosome. RRP6 deletion clearly
suppressed the mRNA expression defect in hpr1-KR cells,
restoring the amounts of YRO2, TDA6, TPO2 and TPO3
acid-induced mRNAs to levels comparable with wt
(Figure 6B). Importantly, while RRP6 inactivation
rescued TPO2 and YRO2 mRNAs levels in hpr1-KR
cells, it did not restore Hpr1 association to these
mRNAs (Figure 6D), further strengthening the fact that
exosomal degradation occurs as a consequence of
decreased Hpr1 recruitment. Moreover, RRP6 deletion
suppressed the strong viability defect of hpr1-KR cells on
acid-containing media (Figure 6C). Taken together, our
data thus establish that in THO sumoylation mutants,
improperly assembled mRNPs of the Haa1 regulon are
targeted for degradation by the exosome.
In THO-inactivation mutants, exosome-mediated
degradation of HSP transcripts was previously reported
to be associated with defective mRNP release from the
transcription site. This leads to the persistence of the cor-
responding genomic loci at the vicinity of the NPC, giving
rise to a detectable chromatin heterogeneity referred to as
DCF (38). While we detected DCF formation both at
HSP104 and acid-induced genes loci upon THO inactiva-
tion, this phenotype was not recorded in hpr1-KR cells
(Supplementary Figure S5E). Loss of THO complex
sumoylation therefore triggers defects in mRNP
assembly and stability for acid-induced mRNAs without
detectable mRNP retention (as probed by DCF).
DISCUSSION
While an increasing number of post-translational modiﬁ-
cations have been reported to inﬂuence mRNP assembly
(26), we describe for the ﬁrst time the involvement of
SUMO in this process. Indeed, we show that the Hpr1
subunit of the THO complex is sumoylated on its
C-terminus, and that its sumoylation/desumoylation regu-
lates the association of the THO complex with mRNPs.
Distinct mechanisms may account for the intriguing
ﬁnding that both the non-sumoylatable (hpr1-KR) and
the hyper-sumoylated (ulp1) mutants display decreased
THO recruitment on mRNPs (Figure 5).
On one hand, SUMO was already reported to modify
the interaction properties of its target proteins with nucleic
acids, either DNA (59) or RNA (52,60). Hpr1
sumoylation could directly interfere with the nucleic-acid
binding properties of the THO complex, for example by
preventing the recently demonstrated interaction between
Tho2 C-terminus and DNA/RNA (5). Interestingly, Siz1
and Siz2, the SUMO ligases for Hpr1 (Figure 3B), have
been reported to bind DNA through their SAP domain
(61,62). For genes at the nuclear periphery, an Hpr1
sumoylation–desumoylation cycle driven by chromatin-
bound SUMO ligases and NPC-bound Ulp1 could be
necessary for mRNA recognition by the THO complex.
On the other hand, sumoylation–desumoylation could
be part of complex formation, as suggested by the fact that
several transcription factors are recruited into co-repres-
sor complexes in a SUMO-dependent manner, but do not
appear to be sumoylated in the ﬁnal assembly (63).
Likewise, Hpr1 sumoylation could modulate the inter-
action of the THO complex with an unknown protein
partner involved in its recruitment onto mRNPs.
Interestingly, sumoylation of intrinsically disordered
domains such as the one encompassing Hpr1 SUMO
acceptor sites has been proposed to create novel inter-
action surfaces (51) which, in the case of the THO
complex, would allow mRNP binding. Following this
initial recruitment, desumoylation of Hpr1 could
remodel the mRNP, resulting in stable association of the
THO complex. Of note, these different scenarios would
involve a transient sumoylation of the THO complex,
which is consistent with the detection of low levels of
sumoylated Hpr1 in wt cells (Figure 3A).
Our data further revealed that sumoylation of Hpr1 is
largely independent from its ubiquitination-dependent
turnover (Figure 4). However, other post-translational
modiﬁcations could also control THO complex activity
as reported for other mRNA-associated factors (26). For
instance, DNA damage-induced phosphorylation of the
THO complex was reported to trigger its dissociation
from RNA in mammalian cells (64). Spatio-temporal
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coordination of these post-translational modiﬁcations is
also expected to be critical for mRNP fate. Strikingly,
the only conserved enzymes reported to associate with
nuclear pores are the SUMO-protease Ulp1 and
the RNA helicase Dbp5, which both target
mRNPs-associated factors. Mechanisms ensuring a local
activation of Dbp5 at the cytoplasmic face of nuclear
pores have been extensively documented (23). While it is
tempting to speculate that Ulp1-dependent remodeling
could occur at the nuclear basket, a free fraction of
Ulp1 may also perform this task in the nucleoplasm. In
both hypotheses, physiological conditions of disturbed
Ulp1 localization (65,66) could inﬂuence mRNP
composition.
In agreement with an overall normal mRNP compos-
ition, ulp1 and hpr1-KR mutants do not display any
mRNA export defects (Supplementary Figure S4), sug-
gesting that the loading of mRNA export factors onto
mRNPs is fully supported by the chromatin-associated
THO complex fraction, or compensated by redundant
pathways (67,68). In contrast, we have demonstrated
that SUMO-dependent control of THO complex recruit-
ment onto mRNAs is critical for acidic stress-induced
gene expression. Indeed, hpr1-KR cells exhibit strongly
reduced levels of mRNAs of the acid-induced, Haa1-de-
pendent regulon and do not survive on acid-containing
media. Altered expression of this subset of genes thus
likely accounts for the previously reported identiﬁcation
of the hpr1D and thp2D THO inactivation mutants in
several genome-wide screens for weak acid sensitive
strains (69–71). The fact that expression of the HAA1
regulator itself and RNAP II recruitment along
acid-induced genes were not affected in hpr1-KR cells sug-
gested that the observed effects on the Haa1 regulon could
be post-transcriptional. Consistently, inactivation of the
exosome (rrp6D) was shown to restore acid-induced
mRNAs levels in the hpr1-KR mutant. These results
indicate that in wt cells, SUMO-dependent recruitment
of the THO complex allows this speciﬁc subset of
mRNPs to escape exosomal degradation, either by
directly protecting the mRNA, or by contributing to the
recruitment of other mRNP-associated factors that would
not have been uncovered in our proteomic analysis of bulk
mRNP composition. Interestingly, sub-optimal mRNP
assembly has already been proposed to trigger
exosome-mediated degradation of heat shock-induced
HSP mRNAs in THO deletion mutants (13,72). Of note,
THO null mutants are extremely sick in combination with
exosome inactivation (13), suggesting that the failure to
degrade improperly assembled mRNPs is detrimental. In
contrast, hpr1-KR cells, which have more limited defects in
mRNP assembly, are not sensitive to exosome inactivation
under normal growth conditions. Moreover, RRP6
deletion rescues the lethality of hpr1-KR cells on acid-con-
taining media, likely by restoring normal levels of mRNAs
of the Haa1 regulon.
mRNAs which are affected upon impairment of THO
function share the common feature of being strongly ex-
pressed, in particular in response to stress (13,17,38,41).
Indeed, strong bursts of mRNP production might be
highly sensitive to any alterations in mRNP packaging
arising upon THO dysfunction. However, loss of Hpr1
sumoylation does not affect the levels of any abundant
or stress-induced mRNAs. Additional features of acid-
induced genes of the Haa1 regulon may render their
mRNAs more sensitive to degradation in hpr1-KR cells.
This might include particular chromatin environment,
nuclear positioning or secondary RNA structures that
could also favor exosomal degradation upon improper
mRNP packaging. While the initial identiﬁcation of this
speciﬁc subset of genes in our transcriptome analysis is
due to the fact that they are already down-regulated in
uninduced hpr1-KR cells, other mRNAs, not expressed
in our conditions, may also require Hpr1 sumoylation
for proper expression. In the future, detailed analysis of
mRNP composition for speciﬁc mRNAs will be required
to further reﬁne the role of THO complex sumoylation in
mRNP assembly, both in normal and environmentally
challenged cells.
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